Grassley Asks Pfizer, Drugmakers How They Treat Whistleblowers

U.S. Senator Charles Grassley asked 16 drugmakers, including Pfizer Inc., AstraZeneca Plc and Eli Lilly & Co., to reveal how they treat whistleblowers who file complaints under the False Claims Act.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.